MYND Life Sciences Inc. to Present at Psychedelics Virtual Investor Conference on October 13

VANCOUVER, BC, Oct. 11, 2021 /PRNewswire/ --MYND Life Sciences Inc. (CSE:MYND)(OTC:MYNDF), based in Vancouver BC, focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, today announcedthat MYND Life Sciences CEO, Dr. Lyle Oberg, M.D, will present live at VirtualInvestorConferences.com's Psychedelics Conference on October 13th.